Our findings revealed that changes in BMI, HbA1c, ALT, and PLT after 3 years of lifestyle intervention were associated with fibrosis progression in T2DM patients with NAFLD. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.